Viracta Therapeutics Inc had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $1.31 on 04/12/24, while the lowest price during the same period was $0.17 on 11/13/24.
52-week price history of VIRX Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Viracta Therapeutics Inc’s current trading price is -88.01% away from its 52-week high, while its distance from the 52-week low is -8.45%. The stock’s price range for this period has remained between $0.17 and $1.31. The Healthcare sector company’s shares managed to surpass a trading volume of around 1.0 million for the day, which was noticeably lower compared to the shares’ average daily volume of 1.39 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
Viracta Therapeutics Inc (VIRX) has experienced a quarterly decline of -54.92% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 6.20M and boasts a workforce of 40 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.3266, with a change in price of -0.4329. Similarly, Viracta Therapeutics Inc recorded 955,129 in trading volume during the last 100 days, posting a change of -73.37%.
VIRX Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for VIRX stands at 7.05. Similarly, the long-term debt-to-equity ratio is also 0.00.
VIRX Stock Stochastic Average
As of today, the raw stochastic average of Viracta Therapeutics Inc over the last 50 days is at 3.51%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 3.51%. Further, the company’s Stochastic %K and %D values for the last 20 days were 5.07% and 6.35%, respectively.
VIRX Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price loss of -72.44% this year. Over the last six months, there has been a stronger performance of -81.30%. The price of VIRX leaped by -28.46% during the last 30 days period. For the last 5-days stocks have slided -17.53%.
